The size of the Molecular weight Marker market in Europe is estimated to be USD 86.92 million in 2020 and is forecasted to grow USD 154.7 million by 2025, registering at a CAGR of 12.23% from 2020 to 2025.
A molecular-weight size marker, also known as a protein ladder, DNA ladder, or RNA ladder, is a set of standards that are used to identify the approximate size of a molecule run on a gel during electrophoresis, utilizing the principle that molecular weight is inversely proportional to migration rate through a gel matrix.
An increase in the popularity of personalized medicines for the treatment of chronic diseases and genetic disorders is a major factor contributing toward the growth of the market. Personalized medicines involve the application of molecular weight markers for the study of individual’s genome, genes, and diseases. Thus, growing adoption of personalized medicines along with the escalating focus on molecular biology research is expected to boost the demand for molecular weight marker products. Technological advancement in molecular biology products, such as PCR and NGS coupled with high-quality molecular weight marker is another major factor contributing toward growth. Advancement in recent times in these products has provided provision for a clearer background and sharp bands. Thus, the demand for molecular weight marker products is expected to grow in the near future, which in turn is expected to boost the market growth.
This research report on the Europe Molecular weight Marker Market has been segmented into the following categories:
Regionally, Europe accounts for the second largest share of the market due to the presence of highly developed healthcare and research infrastructure in the region. Asia Pacific is estimated to witness the highest CAGR during the forecast period, due to the rising focus of CROs and biotechnology companies in this region for drug discovery and development. Moreover, the CROs are focusing on Asian countries such as China and India for clinical trials owing to less stringent government regulations and availability of skilled professionals is further expected to boost the market growth.
Key players dominating the European molecular weight marker market profiled in this report are F Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies, Sigma-Aldrich, Affymetrix, Inc., QIAGEN, Takara Bio Inc., Bio-Rad Laboratories, Promega Corporation, and New England Biolabs.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 DNA
5.1.3 RNA
5.1.4 Protein Ladders
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Pre-stained
5.2.3 Specialty
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Polymerase Chain Reaction (PCR)
5.3.3 Western Blotting
5.3.4 Gel Extraction
5.3.5 Others
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.4 End User
5.4.1 Introduction
5.4.2 Academic Institutes
5.4.3 Pharmaceutical Companies
5.4.4 Contract Research Organizations (CRO)
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By Application
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By Application
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By Application
6.1.5.5 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 F Hoffmann-La Roche AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Agilent Technologies
8.4 Sigma-Aldrich
8.5 Affymetrix Inc.
8.6 QIAGEN
8.7 Takara Bio Inc.
8.8 Bio-Rad Laboratories
8.9 Promega Corporation
8.10 New England Biolabs.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
